Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · March 27, 2015

Impact of ASCT on Survival in Patients With Primary Myelofibrosis

Blood

 

Additional Info

Blood
Impact of Allogeneic Stem Cell Transplantation on Survival of Patients Less Than 65 Years With Primary Myelofibrosis
Blood 2015 Mar 17;[EPub Ahead of Print], N Kröger, T Giorgino, BL Scott, M Ditschkowski, H Alchalby, F Cervantes, A Vannucchi, M Cazzola, E Morra, T Zabelina, M Maffioli, A Pereira, D Beelen, HJ Deeg, F Passamonti

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading